Platelets in the blood enable blood to clot. Abnormally low count of platelets in the blood as a result of presence of any disease or disorder is referred to as thrombocytopenia. Thus, presence of thrombocytopenia in an individual leads to delayed or no blood clotting. The global thrombocytopenia therapeutics market is expected to expand significantly in the near future, owing to high incidence of thrombocytopenia and rising awareness about its treatment options.
Common symptoms of thrombocytopenia are nosebleeds, bruising, rash, and bleeding in the gums and the mouth. Presence of thrombocytopenia is detected with the help of tests viz. complete blood count (CBC) and blood clotting study. In addition, biopsy and bone marrow aspiration are also performed for the diagnosis of thrombocytopenia. Rising rate of morbidity and mortality caused by thrombocytopenia, availability of thrombocytopenia treatment at an affordable cost, and rising awareness about thrombocytopenia and its treatment are some of the factors driving the global thrombocytopenia therapeutics market. On the other hand, stringent regulatory approvals and delay in the diagnosis of thrombocytopenia are factors restraining the global thrombocytopenia therapeutics market. Based on cause of thrombocytopenia, the global thrombocytopenia therapeutics market has been segmented into decreased production of platelets in bone marrow, increased destruction of platelets in the blood stream, medication-induced thrombocytopenia, and others. Based on medications used, the market has been classified into danazol, intravenous immune globulin, rituximab, eltrombopag, romiplostim, splenectomy, corticosteroids, prednisone, and others.
Geographically, the global thrombocytopenia therapeutics market has been segmented as North America, Europe, Asia Pacific, and Rest of World. Presently, North America is leading the global thrombocytopenia therapeutics market, followed by Europe. The rate of morbidity caused by thrombocytopenia is high in developed countries, while the rate of mortality caused by thrombocytopenia is high in developing countries. Favorable reimbursement policies, high health care spending, well-structured regulatory framework, high rate of practicing defined regulations, availability of highly advanced healthcare facilities, and high awareness about thrombocytopenia and its treatment are some of the factors driving the thrombocytopenia therapeutics market in North America and Europe. Asia Pacific is a highly attractive market for thrombocytopenia therapeutics. Factors such as rapidly expanding medical tourism industry in Asia Pacific, primarily in India and China, are expected to attract patients from across the world to this region for treatment. Presence of large pool of patients in Asia Pacific is expected to increase the rate of morbidity caused by thrombocytopenia in the region. In addition, initiatives taken by governments of countries in Asia Pacific to boost the health care industry in these countries, benefits owing to foreign currency differences, and availability of skilled and qualified workforce are some of the factors estimated to attract global players toward the thrombocytopenia therapeutics market in Asia Pacific in the near future. The market in Japan is likely to witness significant growth in the next few years, apart from China and certain countries in Rest of World viz. Argentina, Brazil, and Mexico are estimated to offer higher growth potential to the market than other countries in this region during the forecast period. Countries in Africa are likely to register a sluggish growth rate in the next few years, owing to poorly developed health care infrastructure in these countries.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
The regional analysis covers:
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Please fill the Request TOC form below.
Make an enquiry before buying this Report
Please fill the enquiry form below.